Author

Philip Howe

Medical University of South Carolina

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:metagenomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adriana Aguilar‐MahechaiD· 1 shared Aldo Hernández-CorchadoiD· 1 shared Breege V. HowleyiD· 1 shared Elizabeth Goodwin HilliD· 1 shared Hamed Shateri NajafabadiiD· 1 shared Jean-Sebastien Anoma· 1 shared Jennifer Rutherford BethardiD· 1 shared Josiane LafleuriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriana Aguilar‐MahechaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TACC3-driven translation reprogramming dictates susceptibility or tolerance to mitotic stress

Özge Saatci, Aldo Hernández-Corchado, Adriana Aguilar‐Mahecha, Breege V. Howley, Jennifer Rutherford Bethard, Jean-Sebastien Anoma, Josiane Lafleur, Marguerite Buchanan, Elizabeth Goodwin Hill, Lauren Elizabeth Ball, Mathew Sajish, Philip Howe, Mark Basik, Hamed Shateri Najafabadi, Özgür Şahin

This study identifies TACC3 as a coordinator of translation and epitranscriptomic reprogramming that determines cancer cell sensitivity or tolerance to mitotic stress induced by microtubule targeting agents.

bioRxiv · Sep 22, 2026 · PreprintCancer Biology